Pressure Ulcer Prevention: Where Practice and Education Meet

Brenda S Bos1, Tina M Wangen, Carl E Elbing

  • 1Brenda S. Bos, MS, RN, is Nursing Education Specialist, Department of Nursing, Mayo Clinic, Rochester, Minnesota. Tina M. Wangen, MS, APRN, CNS, is Clinical Nurse Specialist, Department of Nursing, Mayo Clinic, Rochester, Minnesota. Carl E. Elbing Jr, MSN, RN, is Nursing Education Specialist, Department of Nursing, Mayo Clinic, Rochester, Minnesota. Debra J. Rowekamp, MS, RN, is Nursing Education Specialist, Department of Nursing, Mayo Clinic, Rochester, Minnesota. Heather A. Kruggel, MS, RN-BC, is Nursing Education Specialist, Department of Nursing, Mayo Clinic, Rochester, Minnesota. Patricia M. Conlon, MS, APRN, CNS, CNP, is Clinical Nurse Specialist, Department of Nursing, Mayo Clinic, Rochester, Minnesota. Leann M. Scroggins, MS, RN, CRRN, ACNS-BC, is a retired Clinical Nurse Specialist, Department of Nursing, Mayo Clinic, Rochester, Minnesota. Shauna P. Schad, MS, APRN, CNS, is Clinical Nurse Specialist Supervisor, Department of Nursing, Mayo Clinic, Rochester, Minnesota. Julie A. Neumann, MS, RN-BC, is Nursing Education Specialist Supervisor, Department of Nursing, Mayo Clinic, Rochester, Minnesota. Melissa M. Barth, MS, RN, CCRN, is Nursing Education Specialist, Department of Nursing, Mayo Clinic, Rochester, Minnesota. Pamela L. Grubbs, MS, APRN, CNS, is Clinical Nurse Specialist, Department of Nursing, Mayo Clinic, Rochester, Minnesota. Beth A. Sievers, MS, APRN, CNS, is Clinical Nurse Specialist, Department of Nursing, Mayo Clinic, Rochester, Minnesota.

Related Concept Videos

Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
1.1K
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
1.2K
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
625
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
2.0K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.5K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
1.0K